Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 25.50 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc. (MM) | RVNC | NASDAQ | Common Stock | US7613301099 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.35 | -1.35% | 25.5 | 26 | 25.05 | 26 | 25.85 | 17:09:47 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 24.1 | 26 | 1.9 | 7.31% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 937 | 119,551 | $ 25.4430 | $ 3.04M | 137.66k | 12.35 - 28.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:31:36 | formt | 198 | $25.50 | USD |
Revance Therapeutics, Inc. (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 785.89M | 30.82M | $ -89.27M | -3.18 | 0.00 | 10.08M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | - | 99.50% |
Revance Therapeutics, Inc. (MM) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/18/2017 | 16:05 | Business Wire | Revance Therapeutics to Release Third Quarter 2017 Financial.. |
| 10/18/2017 | 08:00 | Business Wire | Revance Completes Patient Enrollment in Phase 2 Program for.. |
| 9/19/2017 | 16:05 | Business Wire | Revance to Participate in the Cantor Fitzgerald 2017 Global.. |
| 9/06/2017 | 16:33 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/06/2017 | 07:30 | Business Wire | Revance Appoints Mark Foley to its Board of Directors |
| 8/30/2017 | 16:05 | Business Wire | Revance to Participate in the 2017 Wells Fargo Securities.. |
| 8/25/2017 | 19:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RVNC Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 26.85 | 27.3 | 25.05 | 26.3268 | 75k | 137k | 101k | -1.35 | -5.03% |
| 1 Month | 24.25 | 28.75 | 23.7 | 27.0546 | 75k | 393k | 159k | 1.25 | 5.15% |
| 3 Months | 22.8 | 28.75 | 22.05 | 25.0024 | 75k | 393k | 143k | 2.7 | 11.84% |
| 6 Months | 20.7 | 28.75 | 18.425 | 23.9804 | 73k | 514k | 176k | 4.8 | 23.19% |
| 1 Year | 14.65 | 28.75 | 12.35 | 21.5880 | 49k | 793k | 176k | 10.85 | 74.06% |
| 3 Years | 19.03 | 42.45 | 12.35 | 23.1422 | 0 | 4M | 220k | 6.47 | 34.00% |
| 5 Years | 21 | 42.45 | 12.35 | 24.0620 | 0 | 5M | 220k | 4.5 | 21.43% |
